about
ELOVL5 mutations cause spinocerebellar ataxia 38Binding of CD157 protein to fibronectin regulates cell adhesion and spreading.CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcomeGenome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathways.The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes.Ectoenzymes and innate immunity: the role of human CD157 in leukocyte trafficking.CD157 at the intersection between leukocyte trafficking and epithelial ovarian cancer invasion.The ADP-ribosyl cyclases--the current evolutionary state of the ARCs.Functional role and prognostic significance of CD157 in ovarian carcinoma.Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines.Human canonical CD157/Bst1 is an alternatively spliced isoform masking a previously unidentified primate-specific exon included in a novel transcript.A novel homozygous change of CLCN2 (p.His590Pro) is associated with a subclinical form of leukoencephalopathy with ataxia (LKPAT).Adult-onset autosomal recessive ataxia associated with neuronal ceroid lipofuscinosis type 5 gene (CLN5) mutations.CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism.Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes
P50
Q24301387-88A4884A-DBCA-4A9E-B7D4-4221ECBE5D9FQ34075993-4DB70168-28ED-4696-862E-4255AB69535BQ34227644-E4E23532-D089-4AD9-9805-D6D1219A0E9CQ34777498-AC047F11-A500-47AE-A943-4DBCBD0E0272Q34998126-26DF8120-85F0-493D-974C-3401EAF006BFQ37410068-67274ECE-EBB9-41AF-81E2-536FCDC1DA4DQ38175728-D2320FA0-4D0B-4313-B5B8-DA482A0B1E28Q38217551-4538B727-C775-4A24-8E90-7FFC776DB61AQ39678760-AB58F1AD-A7AA-43E4-9B4D-79E12717C538Q44976789-CA4D1AE6-09CF-4036-BC9D-74AC949868A2Q46271115-C16E4D32-D827-4589-BFAD-B32E0DBFC7BBQ47731952-F81D17CE-51E7-49A4-AAD3-A28231ADBD69Q48469928-6F2233D3-2D69-43EC-BB97-9F104DFC137CQ49789227-1A3F98C6-EE15-4DB8-A124-335EFF2F167BQ59134968-FB51A97B-C525-45EF-9F9B-32301BB95C90
P50
description
researcher ORCID ID = 0000-0001-5538-6869
@en
wetenschapper
@nl
name
Nicola Lo Buono
@ast
Nicola Lo Buono
@en
Nicola Lo Buono
@es
Nicola Lo Buono
@nl
type
label
Nicola Lo Buono
@ast
Nicola Lo Buono
@en
Nicola Lo Buono
@es
Nicola Lo Buono
@nl
prefLabel
Nicola Lo Buono
@ast
Nicola Lo Buono
@en
Nicola Lo Buono
@es
Nicola Lo Buono
@nl
P1153
26030486900
P21
P31
P496
0000-0001-5538-6869